AHR and T-cell leukemia: Aryl hydrocarbon receptor (AhR) is a ligand-dependent transcription factor expressed by cells of the immune system (137) and many types of human tumors, including urothelial, prostate, breast, ovarian, gastric, liver, pancreatic, lung, medulloblastoma, glioma and T-cell leukemia (138, 139).